A new collaboration with Regeneron Genetics Center combines the power of Utah’s computational genomics with Regeneron’s strength in pharmacogenomics to identify novel targets for drug development.
The Marth laboratory at the USTAR Center for Genetic Discovery has created gene.iobio, a genomics software tool for real-time analysis of disease-causing genetic variants over the web.
The Genomic Revolution Blog explores ethics and consequences of genetic testing in children.
In this Scope Radio interview, Dr. Robert Schlaberg of ARUP and USTAR Genetics discusses a new metagenomics tool that will help diagnose even the most obscure infections.
Read Omicia’s announcement: Opal is chosen for analysis of Genomics England 100,000 genomes cohort.
USTAR Genetics and the Marth Laboratory at University of Utah release bam.iobio, the first web-based genomics app. Read about it on the Genomic Revolution Blog.
Listen to Dr. Gabor Marth speak about the bam.iobio app on this Scope Radio interview.
Omicia gains acclaim as a finalist for the 100,000 Genomes Project.
Read about how USTAR’s computational geneticists are developing software to help identify genetic mutations.
Tracy Manuck, M.D. directs research focusing on treatments for spontaneous preterm birth (SPTB).
USTAR’s VAAST (Variant Annotation, Analysis and Search Tool) is spotlighted at a week long hackathon.
Read the press release on the USTAR/Innovation Utah website.
PHEVOR software from Mark Yandell’s USTAR Lab, identifies undiagnosed illnesses.
UCGD’s mission is to create a genetic discovery pipeline that accurately translates a patient’s complete DNA sequence, revealing the genetic causes of health disorders within seconds.
Phevor (Phenotype Driven Variant Ontological Re-ranking tool) demonstrates its capabilities.
Dr. Mark Yandell speaks about mapping the human genome.
An ethical focus on learning about your DNA.
See how UCGD and Omicia are striving to make genome analysis a common practice for revealing potential disorders.
Read the USTAR press release.
Stephen Guthery, M.D discusses how genomic sequencing can affect treatment plans for rare diseases.
Dr. Gabor Marth tells us why getting your DNA sequence can soon become as common as performing a blood test.
Find out how a woman with a common variable immunodeficiency was identified in this press release.
University of Utah professor Nicki Camp is featured on The Scope.